{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:35:22Z","timestamp":1794245722137,"version":"4.9.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Ministry of Health of the Russian Federation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41429-023-00621-2","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T08:02:54Z","timestamp":1682064174000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A novel antivirulent compound fluorothiazinone inhibits Klebsiella pneumoniae biofilm in vitro and suppresses model pneumonia"],"prefix":"10.1038","volume":"76","author":[{"given":"S. V.","family":"Tsarenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Zigangirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Soloveva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-2965","authenticated-orcid":false,"given":"N. E.","family":"Bondareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Koroleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-5010","authenticated-orcid":false,"given":"A. B.","family":"Sheremet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. N.","family":"Kapotina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. V.","family":"Shevlyagina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Andreevskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. G.","family":"Zhukhovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Filimonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Gintsburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"621_CR1","doi-asserted-by":"publisher","unstructured":"Ramadan RA et al. Carbapenem-resistant Klebsiella pneumoniae among patients with ventilator-associated pneumonia: evaluation of antibiotic combinations and susceptibility to new antibiotics. Infect Drug Resist. 2022. 3537\u201348. https:\/\/doi.org\/10.2147\/IDR.S371248.","DOI":"10.2147\/IDR.S371248"},{"key":"621_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1942-z","volume":"16","author":"S Guo","year":"2016","unstructured":"Guo S, et al. Clinical and molecular characteristics of Klebsiella pneumoniae ventilator-associated pneumonia in mainland China. BMC Infect Dis. 2016;16:1\u20137. https:\/\/doi.org\/10.1186\/s12879-016-1942-z.","journal-title":"BMC Infect Dis"},{"key":"621_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.thromres.2022.01.013.","volume":"211","author":"AA Martyanov","year":"2022","unstructured":"Martyanov AA, et al. Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status. Thrombosis Res. 2022;211:27\u201337. https:\/\/doi.org\/10.1016\/j.thromres.2022.01.013.","journal-title":"Thrombosis Res"},{"key":"621_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-018-0371-8","volume":"7","author":"C Liu","year":"2018","unstructured":"Liu C, Guo J. Characteristics of ventilator-associated pneumonia due to hypervirulent Klebsiella pneumoniae genotype in genetic background for the elderly in two tertiary hospitals in China. Antimicrobial Resist Infect Control. 2018;7:1\u20138. https:\/\/doi.org\/10.1186\/s13756-018-0371-8.","journal-title":"Antimicrobial Resist Infect Control"},{"key":"621_CR5","doi-asserted-by":"publisher","unstructured":"Martin MJ et al. A panel of diverse Klebsiella pneumoniae clinical isolates for research and development. bioRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.08.17.504361.","DOI":"10.1101\/2022.08.17.504361"},{"key":"621_CR6","unstructured":"World Health Organization et al. 2021 antibacterial agents in clinical and preclinical development: an overview and analysis. 2022."},{"key":"621_CR7","doi-asserted-by":"publisher","unstructured":"Filimonova EV Davydova LA, Lysenko MA, Tsarenko SV Interstitial inflammation and pulmonary fibrosis in COVID-19: The potential role of cytostatic therapy for severe lung injury. Respir Med Case Reports. 2022. 101676. https:\/\/doi.org\/10.1016\/j.rmcr.2022.101676.","DOI":"10.1016\/j.rmcr.2022.101676"},{"key":"621_CR8","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/jac\/dkac021","volume":"77","author":"YA Surovoy","year":"2022","unstructured":"Surovoy YA, Burkin MA, Galvidis IA, Bochkov PO, Oganesyan AV, Tsarenko SV. Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation. J Antimicrobial Chemother. 2022;77:1379\u201384. https:\/\/doi.org\/10.1093\/jac\/dkac021.","journal-title":"J Antimicrobial Chemother"},{"key":"621_CR9","doi-asserted-by":"publisher","first-page":"\u0421. 1B. 1.1","DOI":"10.1002\/9780471729259.mc01b01s22","volume":"22","author":"JH Merritt","year":"2011","unstructured":"Merritt JH, Kadouri DE, O\u2019Toole GA. Growing and analyzing static biofilms. Curr Protoc Microbiol. 2011;22:\u0421. 1B. 1.1\u20131B. 1.18. https:\/\/doi.org\/10.1002\/9780471729259.mc01b01s22.","journal-title":"Curr Protoc Microbiol"},{"key":"621_CR10","first-page":"168A","volume":"39","author":"S Ito","year":"1968","unstructured":"Ito S, Karnovsky MJ. Formaldehyde-glutaraldehyde fixatives containing trinitro compounds. J Cell Biol. 1968;39:168A\u2013169A. Part 2","journal-title":"J Cell Biol"},{"key":"621_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41429-022-00504-y","volume":"75","author":"NE Bondareva","year":"2022","unstructured":"Bondareva NE, Soloveva AV, Sheremet AB, et al. Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice. J Antibiot. 2022;75:155\u201363. https:\/\/doi.org\/10.1038\/s41429-022-00504-y.","journal-title":"J Antibiot"},{"key":"621_CR12","doi-asserted-by":"publisher","unstructured":"Sheremet AB et al. Small molecule inhibitor of type three secretion system belonging to a class 2, 4-disubstituted-4H-[1, 3, 4]-thiadiazine-5-ones improves survival and decreases bacterial loads in an airway Pseudomonas aeruginosa infection in mice. BioMed Res Int. 2018. 2018. https:\/\/doi.org\/10.1155\/2018\/5810767.","DOI":"10.1155\/2018\/5810767"},{"key":"621_CR13","doi-asserted-by":"publisher","unstructured":"Koroleva EA et al. Small molecule inhibitor of type three secretion suppresses acute and chronic Chlamydia trachomatis infection in a novel urogenital Chlamydia model. BioMed Res Int. 2015. 2015. https:\/\/doi.org\/10.1155\/2015\/484853.","DOI":"10.1155\/2015\/484853"},{"key":"621_CR14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ja.2015.131","volume":"69","author":"LN Nesterenko","year":"2016","unstructured":"Nesterenko LN, et al. A small-molecule compound belonging to a class of 2, 4-disubstituted 1, 3, 4-thiadiazine-5-ones suppresses Salmonella infection in vivo. J Antibiot. 2016;69:422\u20137. https:\/\/doi.org\/10.1038\/ja.2015.131.","journal-title":"J Antibiot"},{"key":"621_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.32607\/20758251-2012-4-2-87-97","volume":"4","author":"NA Zigangirova","year":"2012","unstructured":"Zigangirova NA, et al. Development of Chlamydial type III secretion system inhibitors for suppression of acute and chronic forms of Chlamydial infection. Acta Nat. 2012;4:87\u201397.","journal-title":"Acta Nat"},{"key":"621_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41429-020-00396-w","volume":"74","author":"NA Zigangirova","year":"2021","unstructured":"Zigangirova NA, et al. Fluorothiazinon, a small-molecular inhibitor of T3SS, suppresses Salmonella oral infection in mice. J Antibiot. 2021;74:244\u201354. https:\/\/doi.org\/10.1038\/s41429-020-00396-w.","journal-title":"J Antibiot"},{"key":"621_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s10753-010-9253-9","volume":"34","author":"V Kumar","year":"2011","unstructured":"Kumar V, Chhibber S. Acute lung inflammation in Klebsiella pneumoniae B5055-induced pneumonia and sepsis in BALB\/c mice: a comparative study. Inflammation. 2011;34:452\u201362. https:\/\/doi.org\/10.1007\/s10753-010-9253-9.","journal-title":"Inflammation"},{"key":"621_CR18","doi-asserted-by":"publisher","unstructured":"McDaniel DK, Allen IC Using Klebsiella pneumoniae to model acute lung inflammation in mice. Mouse Models of Innate Immunity. Humana Press, New York, NY, 2019. P. 169-80. https:\/\/doi.org\/10.1007\/978-1-4939-9167-9_15.","DOI":"10.1007\/978-1-4939-9167-9_15"},{"key":"621_CR19","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3389\/fimmu.2020.01722.","volume":"11","author":"K Vijay","year":"2020","unstructured":"Vijay K. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 2020;11:1722 https:\/\/doi.org\/10.3389\/fimmu.2020.01722.","journal-title":"Front Immunol"},{"key":"621_CR20","doi-asserted-by":"publisher","first-page":"\u0421. 600979","DOI":"10.3389\/fimmu.2021.600979.","volume":"12","author":"MT Meijer","year":"2021","unstructured":"Meijer MT, et al. Tenascin-C deficiency is associated with reduced bacterial outgrowth during Klebsiella pneumoniae-evoked pneumosepsis in mice. Front Immunol. 2021;12:\u0421. 600979 https:\/\/doi.org\/10.3389\/fimmu.2021.600979.","journal-title":"Front Immunol"},{"key":"621_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1155\/MI.2005.88","volume":"2005","author":"T Rukavina","year":"2005","unstructured":"Rukavina T, Vasiljev V, Ticac B. Proinflammatory cytokines in antilipopolysaccharide immunity against Klebsiella infections. Med Inflamm. 2005;2005:88\u201395. https:\/\/doi.org\/10.1155\/MI.2005.88.","journal-title":"Med Inflamm"},{"key":"621_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.36488\/cmac.2021.2.184-194","volume":"23","author":"NA Zigangirova","year":"2021","unstructured":"Zigangirova NA, et al. Antibacterial agents reducing the risk of resistance development. CMAC J. 2021;23:184\u201394.","journal-title":"CMAC J"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00621-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00621-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T23:03:01Z","timestamp":1687820581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-023-00621-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1038\/s41429-023-00621-2","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"29 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}